Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
La Revue Du Praticien
|
March 15, 2019
[Hepatitis B virus infection: control or cure?]
Marc Bourlière, Valérie Oules, Xavier Adhoute
Therapeutic Advances in Gastroenterology
|
December 22, 2018
Sofosbuvir, velpatasvir and voxilaprevir: a new triple combination for hepatitis C virus treatment. One pill fits all? Is it the end of the road?
Marc Bourlière, Olivia Pietri, Paul Castellani, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 31, 2013
How to optimize current therapy of HCV genotype 1 infection with boceprevir
Marc Bourlière, Xavier Adhoute, Astrid Wendt, et al.
Liver Cancer
|
December 5, 2019
Sorafenib: Experience and Better Manage-ment of Side Effects Improve Overall Survival in Hepatocellular Carcinoma Patients: A Real-Life Retrospective Analysis
Jean-Luc Raoul, Xavier Adhoute, Guillaume Penaranda, et al.
Expert Review of Gastroenterology & Hepatology
|
November 24, 2015
Sofosbuvir plus ledipasvir in combination for the treatment of hepatitis C infection
Marc Bourlière, Xavier Adhoute, Christelle Ansaldi, et al.
Clinics and Research in Hepatology and Gastroenterology
|
January 18, 2012
Chronic hepatitis C: treatments of the future
Marc Bourlière, Asma Khaloun, Claire Wartelle-Bladou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 4, 2012
Future treatment of patients with HCV cirrhosis
Marc Bourlière, Asma Khaloun, Claire Wartelle-Bladou, et al.
Gastroenterologie Clinique Et Biologique
|
May 31, 2006
[Sarcoidosis following pegylated interferon therapy: two cases]
Souad Benali, Christian Boustière, Paul Castellani, et al.
European Journal of Gastroenterology & Hepatology
|
September 9, 2011
A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus
Philippe Halfon, Marc Bourliere, Denis Ouzan, et al.
Journal of Hepatology
|
July 14, 2006
Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study
Victor de Lédinghen, Vlad Ratziu, Xavier Causse, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
La Revue Du Praticien
|
March 15, 2019
[Hepatitis B virus infection: control or cure?]
Marc Bourlière, Valérie Oules, Xavier Adhoute
Therapeutic Advances in Gastroenterology
|
December 22, 2018
Sofosbuvir, velpatasvir and voxilaprevir: a new triple combination for hepatitis C virus treatment. One pill fits all? Is it the end of the road?
Marc Bourlière, Olivia Pietri, Paul Castellani, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 31, 2013
How to optimize current therapy of HCV genotype 1 infection with boceprevir
Marc Bourlière, Xavier Adhoute, Astrid Wendt, et al.
Liver Cancer
|
December 5, 2019
Sorafenib: Experience and Better Manage-ment of Side Effects Improve Overall Survival in Hepatocellular Carcinoma Patients: A Real-Life Retrospective Analysis
Jean-Luc Raoul, Xavier Adhoute, Guillaume Penaranda, et al.
Expert Review of Gastroenterology & Hepatology
|
November 24, 2015
Sofosbuvir plus ledipasvir in combination for the treatment of hepatitis C infection
Marc Bourlière, Xavier Adhoute, Christelle Ansaldi, et al.
Clinics and Research in Hepatology and Gastroenterology
|
January 18, 2012
Chronic hepatitis C: treatments of the future
Marc Bourlière, Asma Khaloun, Claire Wartelle-Bladou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 4, 2012
Future treatment of patients with HCV cirrhosis
Marc Bourlière, Asma Khaloun, Claire Wartelle-Bladou, et al.
Gastroenterologie Clinique Et Biologique
|
May 31, 2006
[Sarcoidosis following pegylated interferon therapy: two cases]
Souad Benali, Christian Boustière, Paul Castellani, et al.
European Journal of Gastroenterology & Hepatology
|
September 9, 2011
A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus
Philippe Halfon, Marc Bourliere, Denis Ouzan, et al.
Journal of Hepatology
|
July 14, 2006
Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study
Victor de Lédinghen, Vlad Ratziu, Xavier Causse, et al.
Page
of 2